HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.

Abstract
Cisplatin resistance is a difficult problem in clinical chemotherapy, and the mechanisms involved in cisplatin resistance require further study. In this study, we investigated the role of chloride channel-3 (ClC-3) in cisplatin resistance. Autophagy was demonstrated by accumulation of LC3-II, beclin 1 and Atg12-Atg5. The ultrastructure changes were observed under electron microscope. Chemical staining with acridine orange or MDC was used to detect acidic vesicular organelles. Quantification of apoptosis was detected by PI and Annexin V staining. The mechanisms involved in the Akt pathway and autophagy were studied by western blot analysis. Our results showed that Akt phosphorylation and autophagy were induced by cisplatin in human glioma U251 cells. Specific inhibition of ClC-3 by ClC-3 siRNA sensitized the apoptosis-resistant U251 cells to cisplatin-mediated cell death and downregulated phosphorylated Akt. Interestingly, ClC-3 suppression also inhibited induction of autophagy by cisplatin although the Akt/mTOR pathway was deregulated. Counteracting the autophagic process by 3-methylademine enhanced cytotoxicity of cisplatin, revealing that autophagy plays a key role in chemoresistance. Suppressing the Akt/mTOR pathway by the NADPH oxidase inhibitor diphenyl iodonium (DPI) indicated that cisplatin-induced activation of Akt/mTOR pathway requires generation of reactive oxygen species (ROS) through NADPH oxidase. Collectively, our results suggest that ClC-3 suppression causes the inhibition of Akt and autophagy, which can enhance the therapeutic benefit of cisplatin in U251 cells.
AuthorsJing Su, Ye Xu, Lei Zhou, Hui-Mei Yu, Jin-Song Kang, Ning Liu, Cheng-Shi Quan, Lian-Kun Sun
JournalAnatomical record (Hoboken, N.J. : 2007) (Anat Rec (Hoboken)) Vol. 296 Issue 4 Pg. 595-603 (Apr 2013) ISSN: 1932-8494 [Electronic] United States
PMID23408563 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Wiley Periodicals, Inc.
Chemical References
  • Antineoplastic Agents
  • Chloride Channels
  • ClC-3 channel
  • Enzyme Inhibitors
  • Reactive Oxygen Species
  • NADPH Oxidases
  • MTOR protein, human
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Cisplatin
Topics
  • Antineoplastic Agents (pharmacology)
  • Autophagy (drug effects)
  • Blotting, Western
  • Brain Neoplasms (enzymology, genetics, ultrastructure)
  • Cell Line, Tumor
  • Chloride Channels (genetics, metabolism)
  • Cisplatin (pharmacology)
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Drug Resistance, Neoplasm
  • Enzyme Activation
  • Enzyme Inhibitors (pharmacology)
  • Glioma (enzymology, genetics, ultrastructure)
  • Humans
  • Microscopy, Electron, Transmission
  • NADPH Oxidases (antagonists & inhibitors, metabolism)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA Interference
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction (drug effects)
  • Staining and Labeling
  • TOR Serine-Threonine Kinases (metabolism)
  • Time Factors
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: